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Maintenance of T cell homeostasis is critical 
for normal functioning of the immune system. 
  After thymocyte selection, T cells enter the 
  periphery, where they are maintained as resting 
naive cells. Transient disruption of homeostasis 
occurs when naive T cells undergo antigen-driven 
expansion and acquire eff  ector functions. Eff  ector 
T cells then either undergo apoptosis or survive 
to become memory cells. This process resets T cell 
homeostasis, promotes protective immunity, 
and limits autoimmunity. Thus, T cell homeo-
stasis is ultimately achieved through maintenance 
of distinct T cell populations (naive, eff  ector, 
and memory), although the mechanisms that 
maintain homeostasis in each population are not 
fully understood.
Regulation of responsiveness to soluble cyto-
kines and cytokine availability is one mechanism 
that maintains independent T cell populations. 
For example, whereas naive T cell homeostasis 
is mostly intact in the absence of IL-15 (1, 2), 
IL-15–defi  cient mice are defective in main-
taining memory T cells over time (1–4). This is 
because the slow proliferative turnover that is 
crucial for the maintenance of memory, but not 
naive, CD8+ T cells in vivo is IL-15–dependent 
(2–6). Diff   erential responsiveness to IL-15 
between naive and memory T cells is at least 
partly explained by diff  erences in their IL-15R 
expression (7). IL-7, on the other hand, is critical 
for maintenance of both naive and memory 
T cell homeostasis (8, 9, 10–12). IL-7 regu  lation 
of molecules that promote or inhibit apopto-
sis is likely responsible for the eff  ects of IL-7, 
inasmuch as overexpression of the antiapoptotic 
molecule Bcl-2 or genetic loss of the proapop-
totic molecule Bim largely restores   peripheral 
T cell homeostasis in the absence of IL-7R 
signaling (13–15). Thus, competition for avail-
able IL-7 limits total T cell numbers, whereas 
IL-15 allows proliferative renewal of memory 
CD8+ T cells without major eff  ects on the naive 
T cell pool.
Recent experiments have begun to shed light 
on how proapoptotic Bcl-2 family members 
mechanistically regulate the cell death process. 
For example, genetic loss of the multidomain 
proapoptotic molecules Bax and Bak blocks 
the ability of BH3-only molecules, such as 
Bim, to cause apoptosis (16). Both multidomain 
and BH3-only proapoptotic molecules are pre-
vented from initiating apoptosis through   physical 
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interactions with antiapoptotic Bcl-2 family members such as 
Bcl-2 and Mcl-1 (17–19). However, it remains unclear how 
particular antiapoptotic molecules target specifi  c proapoptotic 
molecules to prevent cell death within lymphocytes.
IL-7 and -15 both increase Bcl-2 expression in naive and 
memory T cells (12, 20–22). Initial studies show that Bcl-2 
is largely required for short-term naive T cell homeostasis 
(23–25), although studies on the role of Bcl-2 in long-term 
naive or memory T cell homeostasis have not been performed. 
This is largely because Bcl-2−/− mice die between 2 and 
6 wk of age (23–25). Thus, interpretation of observations that 
Bcl-2−/− mice have defects in naive T cell homeostasis is 
complicated by the early lethality of these mice. However, 
a recent study showed that the additional loss of one or two 
alleles of Bim completely rescued Bcl-2−/− mice from death 
(26). In contrast, naive T cells from Bim+/−Bcl-2−/− mice 
could not be rescued from death in vitro by IL-7 (26); although 
naive T cell homeostasis in these mice was not directly exam-
ined in vivo.
In this study, we took advantage of Bim+/−Bcl-2−/− mice 
to study the roles of Bcl-2 and Bim in controlling   homeostasis 
of distinct T cell populations. We found that Bim+/−Bcl-2−/− 
mice have substantial defects in their numbers of peripheral 
T cells and that loss of the remaining allele of Bim largely 
restored peripheral T cell numbers. Thymectomy experiments 
show that Bcl-2 is needed to maintain peripheral CD8+ T cell 
survival by antagonizing Bim. We also found that Bim+/−
Bcl-2−/− mice could generate fairly normal numbers of func-
tional memory CD4+ and CD8+ T cells after lymphocytic 
choriomeningitis virus (LCMV) infection, but that these 
cells accumulate because of lymphopenia-driven proliferation. 
Collectively, these data suggest that a Bim/Bcl-2 balance is 
critical for controlling normal homeostasis of naive and mem-
ory T cells.
RESULTS
In Bim−/− or Bim+/− mice, T cells appear to develop 
normally in the absence of Bcl-2
Because loss of a single Bim allele prevents the lethality and 
kidney disease of Bcl-2 defi  ciency (26), we reasoned that 
Bim+/−Bcl-2−/− mice could be used to determine whether 
Bcl-2 is required for T cell survival in vivo when Bim expres-
sion is reduced by 50%. Further, study of Bim−/−Bcl-2−/− 
mice could determine the specifi  c role of Bcl-2 in antago-
nizing Bim. As previously reported for Bcl-2−/−Bim+/+ mice 
(23–25), T cell development in 28-d-old Bim+/−Bcl-2−/− 
mice was not grossly disturbed compared with Bim+/+Bcl-2+/+ 
controls. Bim+/−Bcl-2−/− mice had increased percentages 
and total numbers of CD4 single-positive (SP) thymocytes, 
but no substantial diff  erence in the percentages or numbers of 
CD8 SP thymocytes (Fig. 1, A–D). The slight increase in 
CD4 SP thymocytes was also observed in Bim+/−Bcl-2+/− 
(not depicted) and Bim−/−Bcl-2−/− mice (Fig. 1, A and C). 
There were no signifi  cant diff  erences in percentages or num-
bers of double-negative (CD4−CD8−) or double-positive 
(CD4+CD8+) thymocytes in Bim+/−Bcl-2+/− and Bim−/−
Bcl-2−/− mice (unpublished data). Numbers and percentages 
of LN naive CD4+ and CD8+ T cells were, again, fairly nor-
mal in 28-d-old Bim+/−Bcl-2−/− mice, with only a slight 
  decrease in numbers of naive CD8+ T cells compared with 
Bim+/+Bcl-2+/+ or double-defi  cient mice (Fig. 1, E and F). 
Figure 1.  Dramatic loss of peripheral T cells, but not thymocytes, 
in Bim+/−Bcl-2−/− mice with age. Groups of Bim+/+Bcl-2+/+ (n = 3 
mice/time point; open bars), Bim+/−Bcl-2−/− (n = 4 mice/time point; 
shaded bars), or Bim−/−Bcl-2−/− (n = 4 mice/time point; gray bars) mice 
were killed at either 1 or 3 mo of age, and thymuses, spleens, and periph-
eral LNs were removed. Cells were stained with antibodies against TCR, 
CD44, CD4, and CD8. For thymus analysis, results show the percentage of 
CD4 (A) or CD8 (B) SP cells and the absolute number of CD4 (C) or CD8 (D) 
SP cells ± the SEM. For LN (E and F) and spleen (G and H) analysis, results 
show the absolute number of naive CD44lo CD4+ T cells (E and G) or naive 
CD44lo CD8+ T cells (F and H) ± the SEM. *, statistically signifi  cant differ-
ence between Bim+/−Bcl-2−/− and Bim+/+Bcl-2+/+ mice (number of 
CD4SP cells in thymus, P ≤ 0.02; number of CD4s in LN and spleen, P ≤ 
0.02; number of CD8s in LN and spleen, P ≤ 0.02); †, statistically signifi  -
cant difference between Bim+/−Bcl-2−/− and Bim−/−Bcl-2−/− mice 
(percentage of CD4SP cells in thymus, P ≤ 0.001; number of CD4SP cells in 
thymus, P ≤ 0.03; percentage of CD8SP cells in thymus, P ≤ 0.001; number 
of CD8SP cells in thymus, P ≤ 0.01; number of CD4s in LN, P ≤ 0.05; 
number of CD4s in spleen, P ≤ 0.04; number of CD8s in LN, P ≤ 0.02; 
number of CD8s in spleen, P ≤ 0.05); ¶, statistically signifi  cant difference 
between Bim−/−Bcl-2−/− and Bim+/+Bcl-2+/+ mice (percentage of CD4SP 
cells in thymus, P ≤ 0. 001; percentage and number of CD8SP cells in 
thymus, P ≤ 0.001 and P ≤ 0.03; number of CD8s in spleen, P ≤ 0.03).JEM VOL. 204, July 9, 2007  1667
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Similar results were obtained for spleen (Fig. 1, G and H). 
Bim+/−Bcl-2+/− mice had normal numbers of naive CD4+ 
and CD8+ T cells in the LN and spleen (unpublished data). 
Thus, initial T cell development and seeding of secondary 
lymphoid organs does not require Bcl-2, at least under con-
ditions of Bim heterozygosity.
At 3 mo, the percentages of CD4 and CD8 SP thymo-
cytes were similar for Bim+/−Bcl-2−/−, Bim+/+Bcl-2+/+, and 
Bim+/−Bcl-2+/− (not depicted) mice (Fig. 1, A–D), except 
for a less than twofold decrease in CD4 and CD8 SP thy-
mocyte numbers in Bim+/−Bcl-2−/− mice (Fig. 1, A–D). In 
contrast,  Bim−/−Bcl-2−/− mice had signifi  cantly  increased 
percentages and numbers of CD4 and CD8 SP thymocytes 
(Fig. 1, A–D). In the periphery, Bim+/−Bcl-2−/− mice had 
signifi  cant decreases in the numbers of naive CD4+ ( 2–3-
fold decrease) and naive CD8+ ( 10-fold decrease) T cells 
compared with wt or Bim+/−Bcl-2+/− mice (Fig. 1, E and F), 
whereas Bim−/−Bcl-2−/− mice had near normal numbers of 
peripheral T cell numbers in LN (Fig. 1, E and F) and spleen 
(Fig. 1, G and H). Again, Bim+/−Bcl-2+/− mice had normal 
numbers of naive CD4+ and CD8+ T cells in the LNs and 
spleen (unpublished data). The decreased numbers of mature 
naive T cells in the periphery of Bim+/−Bcl-2−/− mice in the 
face of their near normal numbers of SP thymocytes suggest 
that Bcl-2 promotes the survival of naive T cells. Further, 
the increase in SP thymocytes and the near normal number 
of peripheral T cells in Bim−/−Bcl-2−/− mice suggests that a 
single Bim allele controls T cell numbers in the periphery by 
promoting apoptosis and/or decreasing thymic production.
Bim rapidly kills T cells in the absence of Bcl-2
We used in vitro and in vivo approaches to further evaluate 
Bim and Bcl-2 eff  ects on T cell homeostasis. We cultured 
naive peripheral T cells in vitro in the absence of growth 
and/or survival factors and measured cell survival over time. 
Both CD4+ and CD8+ T cells from Bim+/−Bcl-2−/− mice 
died very quickly ex vivo compared with either Bim+/+
Bcl-2+/+ or double-heterozygous controls (Fig. 2, A and B). 
Further, loss of the remaining Bim allele in double-defi  cient 
mice resulted in survival slightly greater than that observed 
with Bim+/+Bcl-2+/+ mice (Fig. 2, A and B). Because acti-
vated T cells die much more readily than naive T cells ex 
vivo (27), the increased death of the Bim+/−Bcl-2−/− T cells 
could have been caused by the presence of an increased pro-
portion of activated T cells. However, although there were 
slight increases in activated/memory phenotype T cells in 
Bim+/−Bcl-2−/− mice (8.18 ± 1.23% of CD4+ T cells were 
CD44hi in Bim+/+Bcl-2+/+ vs. 16.4 ± 2.61% in Bim+/−
Bcl-2−/− mice), this increase could not account for the death 
of most Bim+/−Bcl-2−/− T cells in culture. Nonetheless, we 
directly examined the death of naive phenotype (CD44lo) 
CD4+ and CD8+ T cells from Bim+/−Bcl-2−/− mice in cul-
ture and found that it was signifi  cantly increased compared 
with naive T cells from either Bim+/+Bcl-2+/+ or Bim+/−
Bcl-2+/− mice (Fig. 2, C and D). Thus, naive T cells from 
Bim+/−Bcl-2−/− mice die at an accelerated rate in vitro during 
withdrawal from survival factors that are normally present 
in vivo, and this rate decreases to wt levels with loss of the 
remaining Bim allele.
As an independent test of the roles of Bim and Bcl-2 in 
the maintenance of peripheral T cells, we used a synthetic 
Bcl-2 antagonist, which binds to Bcl-2, Bcl-xL, and Bcl-w, 
but not to Mcl-1 or A1 (28). Culture of wt T cells from naive 
Figure 2.  Naive Bcl-2–defi  cient T cells exhibit increased Bim-
mediated death. LN cells from individual naive Bim+/+Bcl-2+/+ (fi  lled 
circles); Bim+/−Bcl-2+/− (open triangles); Bim+/−Bcl-2−/− (fi  lled squares); 
or Bim−/−Bcl-2−/− mice (x marks; n = 3 mice/group) were cultured at 
37°C and at various times were stained with antibodies against TCR-β 
and either CD4 or CD8 and propidium iodide, and cell death was assessed 
by fl  ow cytometry. Results show the percentage of CD4+ (A) or CD8+ (B) 
T cells that were PI+ (dead) ± the SEM. *, statistically signifi  cant differ-
ence in the death of CD4+ and CD8+ T cells from Bim+/−Bcl-2−/− mice 
compared with all other groups (for CD4s P ≤ 0.009; for CD8s P ≤ 0.007). 
At 48 and 72 h, the death of CD4+ and CD8+ T cells from Bim−/−Bcl-2−/− 
mice was signifi  cantly decreased compared with Bim+/+Bcl-2+/+ mice 
(for CD4s P ≤ 0.02; for CD8s P ≤ 0.05). Similarly, LN cells were cultured 
at 37°C and stained with antibodies against TCR-β, CD44, CD4 or CD8, 
and AnnexinV-FITC. Cell death was assessed by fl  ow cytometry. Results 
show the percentage of naive (CD44lo) CD4+ (C) and CD8+ (D) T cells that 
were AnnexinV+ (apoptotic or dead) ± the SEM. Death of naive CD4+ and 
CD8+ T cells from Bim+/−Bcl-2−/− mice was signifi  cantly increased com-
pared with all other groups (P ≤ 0.01). These data are representative of 
two independent experiments with similar results. (E) LN cells from either 
C57BL/6 (open squares) or Bim−/− (fi  lled squares) mice were cultured with 
the indicated concentrations of ABT-737 for 24 h. Results show the per-
centage of CD4+ T cells (dead) ± the SEM (similar results were obtained 
with CD8+ T cells). (F) Groups of C57BL/6 mice (n = 4 mice/group) were 
injected i.p. with either vehicle (open bars) or ABT-737 (shaded bars) for 
14 d and killed, and cell numbers were quantifi  ed by fl  ow cytometric 
analysis. Results show the absolute numbers of CD4+ T cells, CD8+ T cells, 
and B cells present in the LN ± the SEM. Similar results were obtained 
in the spleen.1668  BIM/BCL-2 BALANCE CONTROLS T CELL HOMEOSTASIS | Wojciechowski et al.
mice with ABT-737 led to substantial induction of cell death 
(Fig. 2 E). Further, ABT-737 required Bim for its ability to 
kill T cells (Fig. 2 E). Additionally, administration of ABT-737 
in vivo led to a signifi  cant loss of CD4+ and CD8+ T cells 
(and, to a lesser extent, B cells) compared with vehicle-treated 
mice (Fig. 2 F). Because naive T cells normally express little 
Bcl-xL (29) and do not express Bcl-w (unpublished data), the 
eff  ects of ABT-737 in vitro and in vivo are likely caused by 
its ability to bind to Bcl-2. Further, because ABT-737 re-
quires Bim for its ability to kill T cells, these data suggest that 
Bcl-2 is critical to antagonize Bim to promote naive T cell 
survival, even in T cells that have developed in mice with 
normal amounts of Bim and Bcl-2.
Bcl-2 is required for cytokine-driven survival of T cells
We next tested whether cytokines that increase Bcl-2 ex-
pression and promote naive T cell survival in vitro and in vivo 
(9, 12, 30, 31) require Bcl-2 to promote survival. Groups 
of resting, untreated Bim+/+Bcl-2+/+, Bim+/−Bcl-2+/−, and 
Bim+/−Bcl-2−/− mice were killed, and their LN T cells were 
cultured with various doses of cytokines (IL-7, -4, -6, or -15) 
that can prevent naive T cell death in vitro (9, 12, 30–32). 
Both CD4+ and CD8+ T cells from unmanipulated Bim+/−
Bcl-2−/− mice were signifi  cantly less responsive to rescue by 
IL-4 and -7 than those from either Bim+/+Bcl-2+/+ or Bim+/−
Bcl-2+/− mice (Fig. 3, A and C). On the other hand, Bcl-2 
was not required for IL-6–driven survival of CD4+ T cells 
or for most CD8+ T cells (Fig. 3 B). As expected, IL-15 
was unable to rescue CD4+ T cells from death, but largely 
required Bcl-2 to prevent the death of CD8+ T cells (Fig. 3 D). 
The eff  ect of Bcl-2 loss was consistently greater for CD8+ 
than CD4+ T cells, which is consistent with the greater loss 
of CD8+ over CD4+ T cells in vivo observed in Bim+/−
Bcl-2−/− mice (Fig. 3). Impaired cytokine-driven rescue was 
likely not caused by lack of cytokine receptor expression on 
the surface of the T cells in Bim+/−Bcl-2−/− mice because 
these cells express normal levels of CD127 (IL-7Rα) and 
CD132 (cytokine receptor common γ chain [γc]; Fig. 3, E and F). 
Further, levels of CD122 (IL-2Rβ), CD124 (IL-4Rα), and 
IL-15Rα were not decreased on Bim+/−Bcl-2−/− T cells 
(unpublished data). Collectively, these data show that Bcl-2 is 
required downstream of several γc cytokines to optimally 
promote T cell survival.
Bim promotes naive CD8+ T cell death in the periphery
The restoration of naive T cell numbers in Bim−/−Bcl-2−/− 
mice (compared with Bim+/−Bcl-2−/− mice) could be caused 
by the absence of the proapoptotic eff  ects of Bim on thymo-
cytes, causing increased T cell production, or on mature 
  peripheral naive T cells, causing increased survival. We per-
formed two independent sets of experiments to diff  erenti-
ate between these possibilities. First, we injected groups of 
Bim+/+Bcl-2+/+, Bim+/−Bcl-2−/−, or Bcl-2−/−Bim−/− mice 
with neutralizing anti–IL-7 mAb to limit in vivo availability 
of IL-7 and determined peripheral T cell numbers 1 wk 
later, relative to mice treated with an isotype-matched control 
antibody. The effi   cacy of IL-7 neutralization in vivo for each 
mouse was confi  rmed by demonstrating the loss of immature 
(IgM+B220dull) B cells in the BM (unpublished data) (33). 
After IL-7 neutralization, Bim+/+Bcl-2+/+ mice had 65–70% 
of their peripheral naive CD4+ and CD8+ T cells remaining, 
whereas only 45–50% were left in Bim+/−Bcl-2−/− mice (Fig. 
4, A and B). In contrast, there was essentially no decline in 
Figure 3.  Bcl-2 is required for cytokine-mediated survival of naive 
T cells in vitro. LN cells from individual naive Bim+/+Bcl-2+/+ (open 
squares), Bim+/−Bcl-2+/− (open circles), or Bim+/−Bcl-2−/− (fi  lled squares) 
mice (n = 3 mice/group) were cultured at 37°C with IL-4 (A), -7 (B), -6 (C), 
or -15 (D) for 36 h at the concentrations shown. After culture, cells 
were stained with antibodies to TCR and CD8 and propidium iodide and 
cell death was assessed by fl  ow cytometry. Cell death before culture 
was negligible. Results show the percentage of inhibition of cell death 
([{percentage of T cells dead in medium − percentage of T cells dead in 
cytokine} / percentage of T cells dead in medium] × 100) ± the SD, and 
they are representative of three independent experiments. LN cells from 
either Bim+/+Bcl-2+/+ (thick line) or Bim+/−Bcl-2−/− (dotted line) mice 
were also assessed for expression of IL-7Rα (CD127; E) and γc (CD132; F) 
by fl  ow cytometry. Staining of cells with isotype control antibody is 
shown by the thin line). These data are representative of two independent 
experiments with similar results.JEM VOL. 204, July 9, 2007  1669
ARTICLE
the numbers of naive CD4+ or CD8+ T cells in Bcl-2−/−
Bim−/− mice.
However, in vivo IL-7 neutralization can retard thymo-
cyte development in addition to its eff  ects on peripheral 
T cell survival (33, 34). Thus, IL-7–driven decreases in pre–
T cell numbers could have contributed to the observed loss 
of peripheral T cells. In a second experiment, we studied 
the role of Bcl-2 in naive T cell survival in vivo without 
varying T lymphopoiesis by performing adult thymectomy 
to block new T cell production. Groups of Bim+/+Bcl-2+/+, 
Bim+/−Bcl-2−/−, and Bim−/−Bcl-2−/− mice were either 
thymectomized or sham thymectomized. 4 wk later, their 
peripheral naive T cells were analyzed by fl  ow cytometry. 
When compared with their respective sham thymectomy con-
trols, both Bim+/+Bcl-2+/+ and Bim+/−/Bcl-2−/− mice had 
 50% of their naive CD4+ T cells remaining, whereas  75% 
were left in Bim−/−Bcl-2−/− mice (Fig. 4 C). These data 
suggest that molecules other than Bcl-2 may antagonize Bim in 
CD4+ T cells. Conversely, for CD8+ T cells, Bim+/+Bcl-2+/+ 
mice had  50% of their naive CD8+ T cells remaining, 
slightly more ( 65%) naive CD8+ T cells remained in Bim−/−
Bcl-2−/− mice, whereas only  25% were left in Bim+/−
Bcl-2−/− mice (Fig. 4 D). These data suggest that, in vivo, 
a major function of Bcl-2 within naive CD8+ T cells is to 
  antagonize Bim and that naive CD8+ T cells in Bim+/−Bcl-2−/− 
mice are largely maintained by thymic output rather than 
  peripheral survival.
Bcl-2 is not required to generate or maintain memory 
T cells in Bim+/−Bcl-2−/− mice
Although the high levels of Bcl-2 on memory CD4+ and 
CD8+ T cells have been suggested to contribute to their sur-
vival in vivo (9–12, 35), the contribution of Bcl-2 to memory 
T cell survival in vivo has never been experimentally demon-
strated. Consequently, the slightly increased numbers of 
memory phenotype T cells in the absence of exogenous anti-
genic stimulation in older Bim+/−Bcl-2−/− mice suggested 
that perhaps memory T cells do not require Bcl-2 for sur-
vival. To test this, we inoculated groups of Bim+/+Bcl-2+/+, 
Bim+/−Bcl-2−/−, and Bim−/−Bcl-2−/− mice with LCMV and 
used MHC class I and II tetramers to enumerate endog-
enously responding T cells 141 d later. The total numbers 
of Dbgp33+ memory CD8+ T cells were similar for Bim+/+
Bcl-2+/+, Bim+/−Bcl-2−/−, and Bim−/−Bcl-2−/− mice 141 d 
after inoculation (Fig. 5 A). The number of Dbnp396+ CD8+ 
T cells was decreased by approximately twofold in Bim+/−
Bcl-2−/− mice and increased by approximately twofold in 
Bim−/−Bcl-2−/− mice relative to Bim+/+Bcl-2+/+ mice (Fig. 5 A). 
Despite the similar normal numbers of tetramer+ T cells for 
all three mouse lines, the percentage of CD8+ T cells that 
were tetramer+ was signifi  cantly increased in Bim+/−Bcl-2−/− 
mice compared with control Bim+/+Bcl-2+/+ mice for both 
epitopes (Fig. 5 B). Numbers and percentages of Dbnp396-
specifi  c T cells were increased in Bim−/−Bcl-2−/− mice rela-
tive to control Bim+/+Bcl-2+/+ mice (Fig. 5, A and B), likely 
refl  ecting the role of Bim in limiting the numbers of eff  ector 
T cells during the response (36, 37). Similarly, Bim+/−Bcl-2−/− 
mice had a two- to threefold decrease in total numbers of 
memory CD4+ IAbgp61-specifi  c T cells compared with 
Bim+/+Bcl-2+/+ mice, whereas Bim−/−Bcl-2−/− mice exhibited 
an intermediate phenotype (Fig. 5 A, inset). Thus, compared 
with their substantial reductions in naive T cells, Bim+/−
Bcl-2−/− mice maintain relatively normal numbers of LCMV-
specifi  c memory T cells.
It was possible that, in Bim+/−Bcl-2−/− mice, an exaggerated 
expansion of T cells could have contributed to their increased 
numbers of memory T cells. To address this, we quantifi  ed 
LCMV-SP T cell responses at several times after LCMV infec-
tion in both Bim+/−Bcl-2−/− and wt mice. For CD8+ T cells, 
Figure 4.  Bcl-2 is critical to prevent the proapoptotic effects of 
Bim in naive CD8+ T cells in vivo. (A and B) Groups of 6–9-wk-old 
Bim+/+Bcl-2+/+ (n = 9 mice/group), Bim+/−Bcl-2−/− (n = 9 mice/group), 
or Bim−/−Bcl-2−/− (n = 9 mice/group) mice were injected i.p. with 
3 mg of either control IgG (n = 4 mice/genotype) or M25 (n = 5 mice/
genotype) 1 and 4 d before sacrifi  ce. 7 d after the initial injection, LN and 
spleen cells were stained with antibodies against CD4, CD8, CD62L, and 
CD44, data were acquired by fl  ow cytometry, and absolute numbers of 
naive CD44lo CD62Lhi phenotype T cells in each organ were determined. 
Results show the percentage of naive CD44lo CD62Lhi CD4+ (A) and CD8+ 
(B) T cells (combined LN and spleen) remaining in anti–IL-7–treated mice 
relative to control mAb–treated mice. *, statistically signifi  cant difference 
between Bim+/+Bcl-2+/+ and Bim+/−Bcl-2−/− mice (P ≤ 0.04); †, statisti-
cally signifi  cant difference between Bim+/−Bcl-2−/− and Bim−/−Bcl-2−/− 
mice (CD4, P ≤ 0.008; CD8, P ≤ 0.002); ¶, statistically signifi  cant differ-
ence between Bim−/−Bcl-2−/− and Bim+/+Bcl-2+/+ mice (CD4 and CD8, 
P ≤ 0.05). (C and D) Groups of 6–9-wk-old Bim+/+Bcl-2+/+ (n = 3 mice/
group), Bim+/−Bcl-2−/− (n = 8 mice/group), or Bim−/−Bcl-2−/− (n = 6 
mice/group) mice were either thymectomized or sham thymectomized. 
4 wk after thymectomy, spleens and LN cells were stained with antibodies 
against CD4, CD8, and CD44, and data were acquired by fl  ow cytometry. 
Data are pooled from two independent experiments. Results show the 
percentage of naive T cells (CD44lo; combined LN and spleen) remaining in 
thymectomized mice relative to sham-thymectomized controls ± the SEM. 
Similar results were observed at 2 wk after thymectomy. *, statistically 
signifi  cant difference between Bim+/+Bcl-2+/+ and Bim+/−Bcl-2−/− mice 
(P ≤ 0.003); †, statistically signifi  cant difference between Bim+/−Bcl-2−/− 
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numbers of LCMV-SP T cells at the peak of the response 
was actually signifi  cantly decreased in Bim+/−Bcl-2−/− mice 
compared with Bim+/+Bcl-2+/+ mice (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20070618/DC1). 
Interestingly, the overall contraction of the response was 
decreased in Bim+/−Bcl-2−/− mice compared with Bim+/+
Bcl-2+/+ mice, which was refl  ected by an increased per-
centage of tetramer-staining T cells amongst the CD8+ pop-
ulation in Bim+/−Bcl-2−/− mice (Fig. S1). For IAbgp61-SP 
CD4+ T cells, expansion and contraction of the response was 
minimally   aff  ected in Bim+/−Bcl-2−/− mice (Fig. S1). Thus, the 
similar numbers of memory T cells in Bim+/−Bcl-2−/− mice 
compared with Bim+/+Bcl-2+/+ mice was not caused by an 
exaggerated expansion in the former. Instead, the expansion of 
the response was actually less in Bim+/−Bcl-2−/− mice.
We also examined the total numbers of all memory T cells 
in the 141-d-old LCMV-infected mice to determine whether 
memory T cells accumulated at the expense of naive cells 
in Bim+/−Bcl-2−/− mice. Total numbers of CD44hi memory 
CD8+ T cells were reduced by less than twofold in both 
Bim+/−Bcl-2−/− and Bim−/−Bcl-2−/− mice (Fig. 5 C). How-
ever, as assessed on a percentage basis, memory T cells had 
nearly completely overtaken the spleen, as >80% of the 
CD8+ T cells expressed high levels of CD44 (Fig. 5 D). 
Numbers of memory CD4+ T cells were decreased by 
  approximately two- to threefold in Bim+/−Bcl-2−/− mice 
compared with Bim+/+Bcl-2+/+ mice and were intermediate 
in Bim−/−Bcl-2−/− mice (Fig. 5 C). Percentages of activated/
memory CD4+ T cells were also increased in Bim+/−Bcl-2−/− 
mice compared with Bim+/+Bcl-2+/+ mice, although not as 
dramatically as CD8+ T cells (Fig. 5 D). Collectively, these 
results suggest that Bcl-2 is required less for the generation 
and/or maintenance of T cell memory than for the main-
tanance of naive T cells and is not absolutely required to 
combat Bim in memory T cells.
Accumulation of memory T cells in Bim+/−Bcl-2−/− mice 
is caused by increased proliferation rather than increased 
survival or antigen persistence
It was also possible that increased viral persistence might 
contribute to memory T cell accumulation in Bim+/−Bcl-2−/− 
mice. Thus, we assessed viral titers in the livers of mice at 
multiple times after inoculation. We were unable to detect 
virus in any mouse at any time by plaque assay (unpublished 
data). Further, because LCMV persistence is associated with 
decreased functionality of T cells (38, 39), we assessed the 
ability of splenic T cells from Bim+/−Bcl-2−/− mice to pro-
duce IFN-γ after brief stimulation in vitro. Both CD4+ and 
CD8+ LCMV-specifi  c T cells from Bim+/−Bcl-2−/− mice were 
fully capable of producing IFN-γ and IL-2 after restimulation 
in vitro (unpublished data), suggesting that memory T cells 
in Bim+/−Bcl-2−/− mice are functional. Thus, it is unlikely 
that viral persistence contributes to accumulation of memory 
T cells in Bim+/−Bcl-2−/− mice.
We next examined whether memory T cell accumulation 
in Bim+/−Bcl-2−/− mice was caused by increased survival 
or proliferation. To accomplish this, we evaluated the ability 
of IL-7 and -15 to promote endogenous memory T cell sur-
vival in vitro. LN cells from uninfected Bim+/+Bcl-2+/+ and 
Bim+/−Bcl-2−/− mice were cultured with varying concentra-
tions of IL-7 or -15, stained with anti-CD44 mAb to track 
endog  enous activated/memory T cells and with Annexin V to 
assess apoptosis, and analyzed by fl  ow cytometry. Although 
CD44hi T cells from Bim+/+Bcl-2+/+ mice were effi   ciently 
rescued from death by either IL-7 or -15, survival of CD44hi 
T cells from Bim+/−Bcl-2−/− mice was barely aff  ected by either 
cytokine (Fig. 6, A and B). These data suggest that, similar 
to their naive counterparts, endogenous memory T cells require 
Bcl-2 for cytokine-driven survival in vitro.
We next examined proliferative renewal of memory 
CD8+ T cells in Bim+/+Bcl-2+/+, Bim+/−Bcl-2−/−, and Bim−/−
Bcl-2−/− mice, using in vivo BrdU labeling. LCMV-infected 
mice from the experiment in Fig. 5 were injected daily with 
Figure 5.  Bcl-2–independent generation of memory T cells. Groups 
of Bim+/+Bcl-2+/+, Bim+/−Bcl-2−/−, and Bim−/−Bcl-2−/− mice (n = 4–6 
mice/group) were injected i.p. with 2 × 105 pfu LCMV and killed 141 d 
later. Single spleen cell suspensions were stained with MHC tetrameric 
staining reagents and antibodies against CD16/32, CD62L, and either CD4 
or CD8, and then analyzed by fl  ow cytometry. Results show the numbers (A) 
and percentages (B) of LCMV-specifi  c CD8+ (Dbgp33-41 and Dbnp396-404) 
and CD4+ (I-Abgp61-80; inset) T cells in the spleen (106) ± the SEM. 
Spleen cells were also stained with antibodies against CD4, CD8, and 
CD44 to assess the numbers of memory T cells across the genotypes. 
  Results show the total numbers (C) and percentages (D) of CD44hi (memory) 
CD8+ and CD4+ T cells ± the SEM. *, statistically signifi  cant difference 
between Bim+/−Bcl-2−/− and Bim+/+Bcl-2+/+ mice for Dbnp396+ T cells 
(number and percentage of cells, P ≤ 0.02); for total memory CD8s (num-
ber of cells, P ≤ 0.02; percentage of cells, P ≤ 0.001); for total memory 
CD4s (number of cells, P ≤ 0.02; percentage of cells, P ≤ 0.03). †, statisti-
cally signifi  cant difference between Bim+/−Bcl-2−/− and Bim−/−Bcl-2−/− 
mice, total number of Dbnp396+ (P ≤ 0.02); for total memory CD8s 
(percentage of cells, P ≤ 0.001); for total memory CD4s (number of cells, 
P ≤ 0.03). ¶, statistically signifi  cant difference between Bim−/−Bcl-2−/− and 
Bim+/+Bcl-2+/+ mice, total number of IAbgp61+ (P ≤ 0. 005); percentage 
of Dbnp396+ (P ≤ 0.03); for total memory CD8s (number of cells, P ≤ 
0.05). This experiment is representative of two independent experiments 
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1 mg of BrdU during the 14 d before sacrifi  ce. Mice were 
killed 141 d after LCMV inoculation, and the percentage of 
LCMV-specifi  c T cells that were BrdU+ was assessed by 
  intracellular immunofl  uorescence staining and fl  ow cytometry. 
13% of the CD62Lhi D bgp33+ and 17% of the CD62Lhi 
Dbnp396+ T cells in Bim+/+Bcl-2+/+ mice were BrdU+, 
whereas 26% of the CD62Lhi D bgp33+ and 35% of the 
CD62Lhi Dbnp396+ T cells were BrdU+ in Bim+/−Bcl-2−/− 
mice (Fig. 6, C and D). Loss of the remaining Bim allele 
  restored levels of proliferative renewal to normal in both the 
Dbgp33+ and Dbnp396+ memory T cell populations (Fig. 
6, C and D). Thus, enhanced proliferation of LCMV-specifi  c 
memory T cells in Bim+/−Bcl-2−/− mice also contributed to 
their maintenance at near normal levels.
The lymphopenic environment in Bim+/−Bcl-2−/− mice 
could have contributed to the enhanced proliferative re-
newal and subsequent accumulation of memory T cells in 
these mice. We addressed this issue in three independent 
  experiments. First, we attempted to generate mixed BM 
  chimeras in which lineage-depleted BM cells from either 
Bim+/+Bcl-2+/+,  Bim+/−Bcl-2−/−, or Bim−/−Bcl-2−/− mice 
were mixed 50:50 with lineage-depleted BM from Ly5.1 
congenic mice and transplanted into Ly5.1 congenic mice. 
This would allow us to track cells that had originated from 
the mutant mice based on their expression of Ly5.2. Although 
BM from Bim+/+Bcl-2+/+mice was able to establish chime-
rism in recipients, BM from Bim+/−Bcl-2−/− or Bim−/−Bcl-2−/− 
mice showed only a small degree of chimerism at 5 and 8 wk 
in recipient mice. (Fig. S2, available at http://www.jem.org/
cgi/content/full/jem.20070618/DC1). Thus, under com-
petitive conditions, Bcl-2 is required for lymphoid recon-
stitution, which unfortunately precluded study of memory 
T cell homeostasis.
Second, we avoided complications of lymphopenia by 
transferring T cells from the various groups of mice into 
Bim+/+Bcl-2+/+ Ly5.1 congenic recipients. As expected, sig-
nifi  cantly fewer naive CD4+ and CD8+ T cells remained in 
recipients of Bim+/−Bcl-2−/− cells compared with recipients 
of either Bim+/+Bcl-2+/+ or Bim−/−Bcl-2−/− T cells (Fig. 6, 
E and F). Interestingly, similar to naive T cells, signifi  cantly 
fewer memory CD4+ and CD8+ T cells remained in recipients 
Figure 6.  Accumulation of memory T cells in Bim+/−Bcl-2−/− 
mice is caused by increased proliferation rather than survival. 
Groups of Bim+/+Bcl-2+/+ and Bim+/−Bcl-2−/− mice (n = 3 mice/group) 
were killed, and LN cells from individual mice were cultured with the 
indicated concentrations of IL-7 (A) or -15 (B) for 36 h at 37°C. After 
culture, cells were stained with antibodies against TCR-β, CD8, and CD44 
to identify endogenous memory phenotype T cells and with Annexin 
V-FITC (R&D Systems) to identify cells that were dead, and then analyzed 
by fl  ow cytometry. Results show the percentage of inhibition of cell 
death ([{percentage of cells dead in medium – percentage of cells dead 
in cytokine} / percentage of cells dead in medium] × 100) ± the SD. Cell 
death without cytokine was 50.9 ± 2.5% for Bim+/+Bcl-2+/+ and 74.8 ± 
5.4% for Bim+/−Bcl-2−/− mice. *, statistically significant difference 
 between  Bim+/+Bcl-2+/+ and Bim+/−Bcl-2−/− mice for IL-7 (P ≤ 0.001) 
and -15 (P ≤ 0.03). (C and D) Groups of Bim+/+Bcl-2+/+ (n = 6) and 
Bim+/−Bcl-2−/− mice (n = 5) were infected with LCMV. At day 126 after 
infection, mice were injected once daily with BrdU for 14 d. On day 141, 
mice were killed and BrdU accumulation within memory T cells was as-
sessed by staining cells for CD8, CD62L, MHC tetramer, and intracellular 
BrdU. Results show the percentage of tetramer+CD62L+CD8+ T cells that 
are BrdU+ ± the SEM. Percentages of Dbgp33+ (C) and Dbnp396+ (D) 
T cells that were BrdU+ were signifi  cantly increased in Bim+/−Bcl-2−/− 
mice compared with either Bim+/+Bcl-2+/+ or Bim−/−Bcl-2−/− mice 
(P ≤ 0.002 for both). (E and F) Adoptive transfer experiments. T cells 
were purifi  ed from LN and spleens of 2-mo-old Bim+/+Bcl-2+/+, Bim+/−
Bcl-2−/−, and Bim−/−Bcl-2−/− mice. 2 × 106 T cells were transferred 
into Ly5.1 congenic recipient mice (n = 12 mice/group); on days 1 
(n = 6 mice/group) and 10 (n = 6 mice/group), recipient mice were killed 
and donor T cells were quantifi  ed in their LNs and spleens by fl  ow cyto-
metry. Results show the percentage of donor naive and memory CD4+ 
(E) or CD8+ (F) T cells (combined LN and spleen) remaining on day 10, 
relative to the number present on day 1 after transfer ± the SEM. 
(G and H) Purified T cells from 20-mo-old C57BL/6 mice were trans-
ferred into Ly5.1 congenic mice (n = 8). Recipient mice were treated with 
either vehicle (n = 4) or with ABT-737 (n = 4) for 10 d, and the number 
of donor naive and memory T cells was quantifi  ed by fl  ow cytometry. 
Results show the total number of donor CD4+ (G) and CD8+ (H) naive 
versus memory T cells in mice treated with either vehicle (open bars) or 
ABT-737 (shaded bars) ± the SEM. Numbers above the shaded bars indi-
cate the fold decrease in cell number by ABT-737. Similar results were 
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of Bim+/−Bcl-2−/− cells compared with recipients of Bim+/+
Bcl-2+/+ T cells (Fig. 6, E and F). Loss of the remaining allele 
of Bim increased the recovery of memory CD4+, but not 
CD8+ T cells (Fig. 6, E and F).
Third, to avoid complications of memory T cells arising 
in the various genetic backgrounds and potential minor anti-
genic diff  erences in the KO mice that could infl  uence the 
adoptive transfer experiments, we compared the in vivo 
  eff  ects of ABT-737 on naive versus memory T cells. Purifi  ed 
T cells from C57BL/6 mice were transferred into recipient 
mice, which were treated with either vehicle or with ABT-
737 for 10 d, and then killed. The numbers of donor naive 
(CD44lo) and memory (CD44hi) T cells were quantifi  ed. 
Similar to our previous data, ABT-737 caused a substantial 
reduction in naive CD4+ and CD8+ T cells (Fig. 6, G and H). 
ABT-737 also decreased the numbers of transferred memory 
CD4+ and CD8+ T cells, but to a lesser extent than what we 
observed for naive T cells (Fig. 6, G and H). Collectively, 
these data suggest that naive T cells and, to a somewhat lesser 
extent, memory T cells depend on Bcl-2 to combat Bim to 
maintain survival.
D  I  S  C  U  S  S  I  O  N 
Our data demonstrate that Bcl-2 is required to maintain na-
ive T cell survival in vivo and does this largely by inhibiting 
the proapoptotic eff  ects of Bim. Although Bcl-2 is important 
for survival of T cell precursors (40), our studies suggest that 
the defects in naive T cell survival in Bcl-2–defi  cient mice 
are largely intrinsic to mature peripheral T cells and refl  ect 
unopposed Bim activity. First, naive peripheral T cells from 
Bim+/−Bcl-2−/− mice die readily in vitro, and this death is 
prevented by loss of the remaining Bim allele. Second, Bim+/−
Bcl-2−/− mice have nearly normal numbers of thymocytes, 
and thymectomy results in greater loss of naive CD8+ T cells 
in Bim+/−Bcl-2−/− mice than in Bim+/+Bcl-2+/+ mice. Both 
observations are more compatible with a defect in peripheral 
survival than a defect in thymic output. On the contrary, 
these data suggest that, in Bim+/−Bcl-2−/− mice, CD8+ 
T cells are maintained by continual thymic output rather 
than peripheral survival. A specifi  c role for Bcl-2 in suppress-
ing Bim-induced apoptosis is supported by previous evidence 
that genetic loss of other proapoptotic Bcl-2 family members, 
such as Bax or Bik, does not prevent the lethality or defects 
in peripheral T cell homeostasis observed in Bcl-2−/− mice 
(41, 42). For example, the absence of Bax can mostly cor-
rect the loss of thymocytes in Bcl-2−/− mice and IL-7R−/− 
mice, but does not restore peripheral T cell numbers (43). 
Together with our observations, these data suggest that 
peripheral   naive T cell survival requires suppression of Bim 
function either directly by IL-7 or by IL-7–driven induction 
of Bcl-2. This observation for peripheral naive T cells is con-
sistent with previous observations that Bim drives the death 
of activated T cells (36) and that Bim and Bcl-2 are bound to 
one another in resting T cells (44). Bim that is not complexed 
to Bcl-2 would be free to promote apoptosis by activating 
Bax and/or Bak.
Although antagonism between Bim and Bcl-2 is crucial 
for the regulation of T cell homeostasis, other Bcl-2 family 
members also play roles. The following four observations 
  indicate the importance of additional proapoptotic family 
members: a) T cell homeostasis is more severely disturbed 
in Bax/Bak double-defi  cient mice than in Bim−/− mice; b) 
although naive Bim−/−Bcl-2−/− T cells die slower than Bim+/−
Bcl-2−/− T cells in vitro, they still die quite readily; c) total 
loss of Bim (in Bcl-2−/− mice) does not completely restore 
numbers of naive or memory T cells to normal; and d) Bim−/−
Bcl-2−/− mice have signifi  cantly increased numbers of SP 
thymocytes, but normal or slightly decreased numbers of 
  peripheral T cells, suggesting that other proapoptotic Bcl-2 
family members can limit the size of the naive T cell com-
partment. Our preliminary data indicate that Bad and Noxa 
mRNA levels appear to be increased in naive Bim−/−Bcl-2−/− 
T cells. It is possible that, in the absence of Bcl-2, either Bad 
or Noxa can limit peripheral naive T cell survival.
Our data showing the IL-7 dependence of some Bim+/−
Bcl-2−/−, but not Bim−/−Bcl-2−/−, naive T cells suggests 
that IL-7 may have direct or indirect eff  ects on combating 
Bim. One potential candidate for an indirect eff  ect may be 
via IL-7’s eff  ects on Mcl-1, which also appears to be a critical 
mediator of naive T cell homeostasis (45). Deletion of Mcl-1 
results in substantial loss of both thymocytes and peripheral 
T cells. Physical interactions between Mcl-1 and Bak, analo-
gous to those between Bcl-2 and Bim, prevent Bak homodi-
merization, mitochondrial pore formation, and spontaneous 
induction of apoptosis (18) that may bypass Bim. Alter-
natively, in the absence of Bcl-2, Mcl-1 may interfere with Bim 
directly. Although Bcl-xL, which is up-regulated in activated 
T cells (46–49), may be another potential candidate mole-
cule, recent work has shown that Bcl-xL is not normally 
required for memory T cell survival (50). Further, previous 
studies have shown that enforced expression of a human Bcl-2 
or Bcl-xL transgene were not suffi   cient to enhance survival 
of memory T cells after LCMV infection (51, 52). However, 
we have observed that, in the hBcl-2 transgenic mice used by 
Razvi et al. (51), the levels of endogenous Bcl-2 are signifi  -
cantly decreased (unpublished data). Thus, potential eff  ects of 
transgenes on endogenous molecules could have complicated 
the interpretation of these data.
In contrast to its crucial role in maintaining the survival of 
peripheral naive T cells, Bcl-2 did not appear to be strictly 
required for the generation or maintenance of memory T cells 
in Bim+/−Bcl-2−/− mice. However, three key pieces of data 
argue for a prosurvival role for Bcl-2 in memory T cells 
under normal conditions. First, IL-7 and -15 were unable 
to rescue the in vitro apoptosis of Bim+/−Bcl-2−/− memory 
T cells. Second, adoptive transfer studies showed that, similar 
to naive T cells, memory T cells from Bim+/−Bcl-2−/− mice 
were quickly lost when forced to compete with wt T cells in 
a lymphoreplete environment. Third, Bcl-2 inhibition stud-
ies with ABT-737 in wt T cells show that although memory 
T cells are more resistant to the eff  ects of ABT-737, they are 
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the in vivo accumulation of memory T cells in Bim+/−
Bcl-2−/− mice and their rapid loss in normal recipient mice 
is resolved by the increased proliferation of the LCMV-SP 
memory T cells in lymphopenic Bim+/−Bcl-2−/− mice. In 
addition, the increased proliferation of LCMV-SP T cells 
likely contributed to the lessening of the contraction of the 
T cell response in Bim+/−Bcl-2−/− mice. Thus, although 
memory T cells appear to be slightly less aff  ected by the loss 
of Bcl-2 than naive T cells, under normal conditions, Bcl-2 is 
critical to maintain both memory and naive T cell homeosta-
sis. In summary, we have investigated for the fi  rst time the 
involvement of Bcl-2 in regulating survival of naive and 
memory T cell populations and have shown that Bcl-2 pro-
motes T cell survival by antagonizing Bim.
MATERIALS AND METHODS
Mice. Bim−/− mice were a gift from P. Bouillet and A. Strasser (Walter and 
Eliza Hall Institute, Melbourne, Australia) and have been backcrossed to 
C57BL/6 mice for at least 14 generations. Breeding pairs of Bcl2Tm1sjk mice 
were obtained from The Jackson Laboratory and were mated to Bim−/− 
mice to generate Bim+/−Bcl-2+/−, Bim+/−Bcl-2−/−, and Bim−/−Bcl-2−/− 
mice. Mice were genotyped by PCR of tail DNA (36). B6.SJL-Ptprca/
BoAiTac (Ly5.1 congenic) mice used as recipients in adoptive transfer 
experiments were purchased from Taconic Farms or were bred in-house. All 
animal protocols were reviewed and approved by our Institutional Animal 
Care and Use Committee.
IL-7 depletion. M25 antibody was purifi  ed from ascitis fl  uid harvested 
from nude mice that had been injected with M25 hybridoma cells. Antibody 
was purifi  ed from ascitic fl  uid by precipitation with ammonium sulfate, fol-
lowed by DEAE-cellulose column chromatography. Fractions containing 
mouse IgG2b were pooled, dialyzed against 0.15 M NaCl, and concentrated 
by pressure fi  ltration. Mice were injected intraperitoneally every other day 
with 3 mg of M25 antibody or with MPC-11 isotype control.
Adult thymectomy. 6–9-wk-old mice were anesthetized with 200 mg/Kg 
avertin and given 0.03 mg/kg atropine i.p. to reduce bradycardia. Under 
anesthesia, mice were immobilized on a surgical tray ventral side up. Using 
sterile technique, a small incision was made through the skin of the neck 
extending down to the middle of the ribcage with a sterile scalpel. The sub-
mandibular glands were pushed aside to expose the thin layer of tissue, which 
was cut to expose the thoracic cavity. A second midline incision was made 
to the level of the second rib. One side of the ribcage was lifted with a sterile 
forceps, and a suction bell constructed from a glass Pasteur pipette was in-
serted into the thoracic cavity. In sham-thymectomized mice, the suction 
bell was then removed from the thoracic cavity and the opening was sutured 
with surgical staples. In thymectomized mice, suction was applied to draw 
one lobe of thymus into the bell; this was repeated for the other thymic lobe. 
After removal of both thymic lobes, the skin was sutured with sterile surgical 
staples. Mice were then placed under a heat lamp and monitored until they 
awoke from anesthesia.
Adoptive transfer experiments. LN and spleen cells from 2-mo-old 
mice were purifi  ed by negative selection using a Pan T cell isolation kit 
and an autoMACS cell separator (Miltenyi Biotech). Purity of T cells 
  using this technique was >95%. Approximately 2 × 106 purifi  ed T cells 
were labeled in vitro with 5-(and-6)-carboxyfl   uorescein diacetate and 
0.5 μM CFSE and transferred into Ly5.1 recipient mice via i.v. injec-
tion. On days 1 and 10 after transfer, groups of recipient mice were killed 
and LNs (axillary, brachial, inguinal, and mesenteric) and spleens were 
removed and stained with antibodies against CD4 or CD8, Ly5.1, and 
CD44. Data were acquired on a FACSCalibur (BD Biosciences) fl  ow 
cytometer and analyzed using CellQuest software (BD Biosciences). For 
analysis, cells were gated on Ly5.1+CFSE+ (0–2 divisions) before analysis 
of CD44 expression.
Competitive BM reconstitution experiments. BM was harvested from 
the femurs of Bim+/+Bcl-2+/+, Bim+/−Bcl-2−/−, Bim−/−Bcl-2−/−, and B6.
SJL-Ptprca/BoAiTac mice. Lineage-negative BM cells were purifi  ed using a 
lineage cell depletion kit and an AutoMacs Separator (Miltenyi Biotech). 
Lineage-depleted BM cells from either Bim+/+Bcl-2+/+, Bim+/−Bcl-2−/−, or 
Bim−/−Bcl-2−/− mice were mixed in a 50:50 ratio with lineage-depleted BM 
cells from B6.SJL-Ptprca/BoAiTac mice and 106 cells were injected i.v. into 
lethally irradiated (2 × 500 rads) recipient B6.SJL-Ptprca/BoAiTac mice. At 
5 and 8 wk after transfer, mice were bled and chimerism was tested by stain-
ing the cells with antibodies against CD4, CD8, Ly5.2, and Ly5.1.
Viruses. The Armstrong-3 strain of LCMV, a gift from R. Ahmed (Emory 
University, Atlanta, GA), was grown in BHK-21 cells; the number of 
plaque-forming units (pfu) was assayed on Vero cells as previously described 
(53). Mice were injected i.p. with 0.25 ml of 2 × 105 pfu LCMV diluted in 
balanced salt solution.
Creation of MHC tetrameric staining reagents. Class II MHC tetra-
meric staining reagents were created as previously described (54, 55). In 
brief, recombinant baculoviral plasmids encoding I-Ab plus genetically linked 
peptide were transfected into SF-9 insect cells to produce baculoviral stocks. 
Baculoviral SF-9 supernatant was harvested and used to infect Hi-5 insect 
cells (Invitrogen). After infection, Hi-5 cells produced and secreted assem-
bled monomeric I-Ab peptide complexes. Hi-5 cell supernatants were har-
vested and monomers were purifi  ed by affi   nity chromatography using 
anti–I-Ab antibody (M5-114) and eluted with a high pH buff  er. After purifi  -
cation of monomeric MHC–peptide complexes, the complexes were buff  er-
exchanged into biotinylation buff  er and biotinylated with the recombinant 
enzyme BirA (Avidity, Inc.). After biotinylation, unbound biotin was removed 
and buff  er-exchanged into PBS using Centricon concentrators. Biotinylated 
monomers were coupled to streptavidin-phycoerythrin and subsequently 
subjected to size exclusion fast protein liquid chromatography on Superdex 200 
(GE Healthcare) to separate large multimeric complexes from excess free 
monomeric complexes.
MHC I tetramers were provided by A. Zajac (University of Alabama, 
Birmingham, AL). The methodology for preparation of MHC class I tetra-
mers was modifi  ed from the protocol described by Altman and coworkers 
(56). Recombinant MHC class I molecules fused to a BirA substrate peptide, 
and recombinant β2-microglobulin were produced in Eschericia coli BL21 
(DE3) cells as previously described (57). MHC–peptide complexes were 
generated by folding class I heavy chains in vitro with β2-microglobulin and 
defi   ned LCMV-derived peptide epitopes and enzymatically biotinylated 
with recombinant BirA enzyme. Biotinylated MHC monomers were puri-
fi  ed over a Sepharose–G75 column (GE Healthcare), and fractions contain-
ing biotinylated class I–β2-microglobulin–peptide complexes were pooled 
and exchanged into 20 mM Tris, pH 8.0, using centrifugal fi  ltration devices 
(Millipore). The complexes were further purifi  ed by ion exchange chroma-
tography using a QM–Sepharose column (GE Healthcare). Appropriate frac-
tions were concentrated and dialyzed against PBS containing 2 mM EDTA, 
1 μg/ml leupeptin, 1 μM pepstatin, and 200 μM PMSF (Sigma-Aldrich). 
The complexes were tetramerized by the step-wise addition of allophycocyanin-
conjugated streptavidin (Invitrogen).
Flow cytometry. Spleens, LNs (axillary, inguinal, and brachial), and thy-
muses were harvested, and single-cell suspensions were counted with a 
Coulter Counter (model Z2; Beckman Coulter). 106 cells were stained with 
fl  uorochrome-labeled antibodies (spleen and LNs [anti-CD4, -CD8, -CD44, 
and -CD62L]; thymus [anti-CD4, -CD8, -CD44, -CD25]), and data was 
acquired using a FACSCalibur fl  ow cytometer. Data were analyzed with 
CellQuest software. To detect antigen-specifi  c CD4+ T cells, 2 × 106 LN 
or spleen cells/well was stained in triplicate with I-Abgp61-80 tetrameric 
staining reagents for 2 h at 37°C. During the last 45 min of incubation, cells 1674  BIM/BCL-2 BALANCE CONTROLS T CELL HOMEOSTASIS | Wojciechowski et al.
were stained with anti–CD4-allophycocyanin, anti-CD16/32 biotin, and 
anti–CD44-FITC antibodies. Cells were washed twice, stained with SA-
Cychrome, washed twice again, and fi   xed with 2% paraformaldehyde. 
CD4+, CD16/32− cells were gated and analyzed by dot plots that displayed 
CD44 versus tetramer to reveal small populations of LCMV-SP T cells. 
LCMV-SP. CD8+ T cells were detected by staining 2 × 106 LN or spleen 
cells/well in triplicate with Dbgp33, Dbnp396, or Kbnp205 tetrameric stain-
ing reagents for 90 min at 4°C. During the last 45 min of incubation, cells 
were stained with antibodies directed against various surface markers (CD8, 
CD44, CD62L, and CD127 from BD Biosciences, eBioscience, or pro-
duced in-house), washed, and fi  xed with 2% paraformaldehyde. Gates were 
drawn around tetramer+ populations based on background staining of unin-
fected animals (generally <0.05% for class II tetramer staining and <0.1% for 
class I tetramer staining). A minimum of 5 × 105 events were acquired on a 
FACSCalibur fl  ow cytometer and analyzed using CellQuest software.
To assess naive T cell viability, spleen or LN cells were cultured in vitro 
in Kappler-Marrack complete tumor medium with or without the indicated 
concentrations of survival cytokines (IL-4, -6, -7, and -15, all purchased 
from R&D Systems) as previously described (31, 58). At the indicated times 
after culture, cells were stained with antibodies against TCR-β, CD4 or 
CD8, and propidium iodide (5 μg/ml), and cell viability was assessed by 
fl  ow cytometry. To assess viability of memory versus naive T cells, cells were 
stained with antibodies against CD4, CD8, CD44, and AnnexinV-FITC 
(R&D Systems) and analyzed by fl  ow cytometry.
Assessment of in vivo proliferation was performed using a BrdU Flow 
kit (BD Biosciences). In brief, mice were inoculated i.p. with 2 × 105 pfu 
LCMV and injected i.p. with 1 mg of BrdU daily for 14 d, beginning 127 d 
after inoculation. Mice were killed 141 d after inoculation, and single-spleen 
cell suspensions were surface stained with antibodies against CD8 and 
CD62L and MHC tetramers, followed by intracellular staining with anti-
BrdU antibody according to the instructions in the kit. Stained cells were 
analyzed with a FACSCalibur fl  ow cytometer and CellQuest software.
Intracellular cytokine staining was performed as previously described 
(57). In brief, spleen cells from LCMV-infected or -uninfected mice were 
cultured at 37°C for 4–5 h with or without various LCMV peptides (10 μg/ml 
GP61-80; 1 μg/ml GP33-41, NP396-404) and 10 μg/ml Brefeldin A. After 
culture, cells were stained for cell surface markers (CD4, CD8, CD44, and 
antibodies from BD Biosciences) for 45 min at 4°C. Cells were washed, 
fi  xed, and permeabilized with 0.03% saponin and stained intracellularly with 
PE-labeled anti–IFN-γ or anti–IL-2 antibody (BD Biosciences). A minimum 
of 5 × 105 events were acquired on a FACSCalibur fl  ow cytometer and 
analyzed using CellQuest software.
Synthetic Bcl-2 inhibitor. ABT-737 was produced and provided by Abbott 
Laboratories, as previously described (28), and dissolved and diluted in 30% 
polyethylene glycol, 5% Tween-80, and 65% of a 5% dextrose in water solution. 
Mice were injected i.p. once a day with 75 mg/kg in a volume of 0.2 ml.
Statistical analyses. Statistical analyses were performed using a 2-sample 
Student’s t test with Minitab for Windows Software (Release 14).
Online supplemental materials. Fig. S1 shows the kinetics of the LCMV-
specifi  c CD4+ and CD8+ T cell responses in Bim+/−Bcl-2−/− compared 
with Bim+/+Bcl-2+/+ mice. Fig. S2 shows that Bcl-2 is critical to combat 
proapoptotic molecules other than Bim to allow BM reconstitution when 
done in a competitive manner. The online version of this article is available 
at http://www.jem.org/cgi/content/full/jem.20070618/DC1.
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